![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/5377 | (2006.01) |
A61K 31/4412 | (2013.01) | ||
A61K 31/4412 | (2006.01) | ||
A61K 31/5377 | (2013.01) | ||
A61K 45/06 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
A61K 31/436 | (2013.01) | ||
A61P 35/02 | (2006.01) | ||
A61K 45/06 | (2006.01) | ||
A61K 31/53 | (2013.01) | ||
A61K 31/573 | (2006.01) | ||
A61K 31/573 | (2013.01) | ||
A61K 31/704 | (2006.01) | ||
A61K 31/704 | (2013.01) | ||
A61K 33/24 | (2019.01) | ||
A61K 31/7068 | (2013.01) | ||
A61K 31/436 | (2006.01) | ||
C07D 213/64 | (2013.01) | ||
A61K 31/4745 | (2006.01) | ||
A61K 31/4745 | (2013.01) | ||
A61K 31/53 | (2006.01) | ||
A61K 31/675 | (2013.01) | ||
C07D 405/12 | (2013.01) | ||
A61K 31/675 | (2006.01) | ||
A61K 31/7068 | (2006.01) | ||
A61K 33/243 | (2019.01) | ||
C07D 405/12 | (2006.01) | ||
A61K 33/24 | (2013.01) | ||
C07D 213/64 | (2006.01) | ||
A61P 25/00 | (2018.01) | ||
A61P 25/00 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 43/00 | (2006.01) | ||
A61P 35/02 | (2018.01) | ||
A61P 43/00 | (2018.01) |
(11) | Number of the document | 2836216 |
(13) | Kind of document | T |
(96) | European patent application number | 13776380.1 |
Date of filing the European patent application | 2013-04-12 | |
(97) | Date of publication of the European application | 2015-02-18 |
(45) | Date of publication and mention of the grant of the patent | 2022-06-08 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2013/036452 |
Date | 2013-04-12 |
(87) | Number | WO 2013/155464 |
Date | 2013-10-17 |
(30) | Number | Date | Country code |
201261624194 P | 2012-04-13 | US | |
201361785169 P | 2013-03-14 | US |
(72) |
KEILHACK, Heike , US
KNUTSON, Sarah, Kathleen , US
KUNTZ, Kevin, Wayne , US
|
(73) |
Epizyme, Inc. ,
400 Technology Square, 4th Floor, Cambridge, MA 02139,
US
|
(54) | COMBINATION THERAPY FOR TREATING CANCER |
COMBINATION THERAPY FOR TREATING CANCER |